Optional treatment of renal anemia

Maria Wanic-Kossowska; Lidia Kozioł; Agnieszka Szczepańska

ISSN: 1505-8409

Przewodnik Lekarza/Guide for GPs

Current issue Archive About the journal Supplements Contact Instructions for authors

5/2009
vol. 12

Send email

Copy url:

abstract:

Optional treatment of renal anemia

Maria Wanic-Kossowska

,

Lidia Kozioł

,

Agnieszka Szczepańska

Przew Lek 2009; 5: 61-66

Online publish date: 2009/10/05

View full text Get citation

Anemia, due to lack of erythropoietin, is a serious complication in nondialysed patients with chronic kidney disease (CKD). Anemia treatment with erythropoietin stimulating agents permit achieve target hemoglobin level in nondialysed patients with CKD. Anemia treatment has a beneficial effect on the function and heart structure and prevents progressive development of cardiovascular complications in CKD patients.

keywords:

Optional treatment of renal anemia

Maria Wanic-Kossowska , Lidia Kozioł , Agnieszka Szczepańska

chronic kidney disease, anemia, erythropoietin stimulating agents

Maria Wanic-Kossowska

,

Lidia Kozioł

,

Agnieszka Szczepańska